Sign In
Buy HALO
$82.54
-0.760 (-0.91%)
At Close: Jul 31, 2026
Is Halozyme Therapeutics (HALO) Stock a Solid Choice Right Now?
02:30pm, Thursday, 19'th Mar 2020
Halozyme Therapeutics (HALO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Is Halozyme Therapeutics (HALO) Stock a Solid Choice Right Now?
02:30pm, Thursday, 19'th Mar 2020
Halozyme Therapeutics (HALO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Does Halozyme Therapeutics, Inc. (NASDAQ:HALO) Have A Volatile Share Price?
11:17am, Wednesday, 18'th Mar 2020
If you own shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO) then it's worth thinking about how it contributes to...
Chevy Chase Trust Holdings Inc. Buys Shares of 1,500 Halozyme Therapeutics, Inc. (NASDAQ:HALO)
10:16am, Wednesday, 18'th Mar 2020
Chevy Chase Trust Holdings Inc. bought a new stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commiss
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
07:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …
10 Small-To-Mid-Cap Biotech Ideas For When The Coronavirus Fades
09:13pm, Tuesday, 17'th Mar 2020
The COVID-19-induced sell-off has taken a toll on stocks across sectors. An analyst at Cantor Fitzgerald presented his take on how biotech investing could look after the coronavirus pandemic and highl
ProShare Advisors LLC Reduces Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
09:38am, Tuesday, 17'th Mar 2020
ProShare Advisors LLC reduced its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 8.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commiss
361 Capital LLC Sells 85,238 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
08:20am, Monday, 16'th Mar 2020
361 Capital LLC reduced its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 52.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor o
Halozyme: The Upside Is Still There
08:08pm, Thursday, 12'th Mar 2020
The restructuring of the company post PEGPH20 failure and prioritization of Enhanze business is a solid positive for Halozyme. Commercial launch of Darzalex SC
89,573 Shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO) Bought by Amia Capital LLP
08:56am, Wednesday, 11'th Mar 2020
Amia Capital LLP acquired a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 89,573 shares of the bi
Halozyme Therapeutics (NASDAQ:HALO) Shares Down 5%
07:16am, Tuesday, 10'th Mar 2020
Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares traded down 5% during trading on Monday . The company traded as low as $17.96 and last traded at $18.51, 2,136,697 shares traded hands during mid-day t
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Pictet Asset Management Ltd.
09:56am, Monday, 09'th Mar 2020
Pictet Asset Management Ltd. lessened its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 4.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The
Bank of Montreal Can Acquires 104,125 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
08:44am, Sunday, 08'th Mar 2020
Bank of Montreal Can grew its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 110.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securitie
